The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection

Clinics

Volumn 67, Issue 7, 2012, Pages 805-813

  Commodaro, Alessandra Gonçalves ^a,b   Pedregosa, Juliana Figueredo ^a   Peron, Jean Pierre ^c   Brandão, Wesley ^c   Rizzo, Luiz Vicente ^b   Bueno, Valquiria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Foxp3; FTY720; Rejection; Th17; Tolerance; Transplantation

Indexed keywords

CYTOKINE; DRUG DERIVATIVE; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN DERIVATIVE; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; MALE; METABOLISM; MOUSE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SKIN TRANSPLANTATION; TH17 CELL;

ANIMALS; CYTOKINES; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROPYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; SKIN TRANSPLANTATION; SPHINGOSINE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84867094673     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(07)17     Document Type: Article

References (39)

1. Rosenberg AS, Singer A. Evidence that the effector mechanism of skin allograft rejection is antigen-specific. Proc Natl Acad Sci USA. 1988;85(20):7739-42, http://dx.doi.org/10.1073/pnas.85.20.7739.
2. Lee RS, Grusby MJ, Glimcher LH, WinnHJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med. 1994;179(3):865-72, http://dx.doi.org/10.1084/jem.179.3.865.
3. Chen W, Murphy B, Waaga AM, Willett TA, Russell ME, Khoury SJ, et al. Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cells clones transfer delayed-type hypersensitivity responses in vivo. Transplantation. 1996;62(6):705-10, http://dx.doi.org/10.1097/00007890-199609270-00001.
4. Sayegh MH, Turka LA. The role of T-cell co stimulatory activation pathways in transplant rejection. N Engl J Med. 1998;338(25):1813-21.
5. Chattopadhyay K, Bhatia S, Fiser A, Almo SC, Nathenson SG. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein. J Immunol, 2006;177(6):3920-9.
6. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999;162(9):5317-26.
7. Jee Y, Piao WH, Liu R, Bai XF, Rhodes S, Rodebaugh R, et al. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin Immunol. 2007;125(1):34-42, http://dx.doi.org/10.1016/j.clim.2007.05.020.
8. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest. 2004;114(10):1398-403.
9. Karim M, Feng G, Wood KJ, Bushell AR. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood. 2005;105(12):4871-7, http://dx.doi.org/10.1182/blood-2004-10-3888.
10. Mitchell P, Afzali B, Lombardi G, Lechler RI. The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant. 2009;14(4):326-31, http://dx.doi.org/10.1097/MOT.0b013e32832ce88e.
11. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148(1):32-46, http://dx.doi.org/10.1111/j.1365-2249.2007.03356.x.
12. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821-52, http://dx.doi.org/10.1146/annurev.immunol.25.022106.141557.
13. de Jong E, Suddason T, Lord GM. Translational mini-reviews series on Th17 cells: Development of mouse and human T helper 17 cells. Clin Exp Immunol. 2010;159(2):148-58, http://dx.doi.org/10.1111/j.1365-2249.2009.04041.x.
14. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cells effector cytokines in inflammation. Immunity. 2008;28(4):454-67, http://dx.doi.org/10.1016/j.immuni.2008.03.004.
15. Liao JJ, Huang MC, Goetzl EJ. Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate. J Immunol. 2007;178(9):5425-28.
16. Isoyama N, Takai K, Tsuchida M, Matsumura M, Naito K. Evidence that FTY720 induces rat thymocyte apoptosis. Transpl Immunol. 2006;15(4):265-71, http://dx.doi.org/10.1016/j.trim.2006.02.004.
17. Xie JH, Nomura N, Koprak SL, Quackenbush EJ, Forrest MJ, Rosen H. Sphingosine-1-phosphate receptor agonist impairs the efficiency of the local immune response by altering trafficking of naive and antigenactivated CD4+ T cells. J Immunol. 2003;170(7):3662-70.
18. Sawicka E, Dubois G, Jarai G, Edwards M, Thomas M, Nicholls A, et al. The sphingosine1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+CD25+ T-regulatory cells and enhances their functional activity. J Immunol. 2005;175(12):7973-80.
19. Fujiwara I, Nakajima H, Matsuda T, Mizuta N, Yamagishi H, Oka T. Prolongation of concordant xenograft survival by a newly developed drug, FTY720. Transplant Proc. 1999;31(7):2831-33, http://dx.doi.org/10.1016/S0041-1345(99)00582-5.
20. Wang W, Graeler MH, Goetzl EJ. Type 4 sphingosine 1-phosphate G protein coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J. 2005;19(12):1731-33.
21. Jin J, Yang SH, Park J, Lee C, Lee J, Kim SM, Kim YS. Fragile maintenance of allograft tolerance induced by lymphocyte sequestration and costimulation blockade. Transpl Immunol. 2009;21(4):221-7, http://dx.doi.org/10.1016/j.trim.2009.06.001.
22. Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V. FTY720 in combination with cyclosporine-an analysis of skin allograft survival and renal function. Int Immunopharmacol. 2006;6(13-14):1911-8, http://dx.doi.org/10.1016/j.intimp.2006.07.014.
23. Gallo AP, Silva LB, Franco M, Burdmann EA, Bueno V. Tacrolimus in combination with FTY720-an analysis of renal and blood parameters. Int Immunopharmacol. 2006;6(13-14):1919-24, http://dx.doi.org/10.1016/j.intimp.2006.07.012.
24. Lopes CT, Gallo AP, Palma PV, Cury PM, Bueno V. Skin allograft survival and analysis of renal parameters after FTY720 + Tacrolimus treatment in mice. Transplant Proc. 2008;40(3):856-60, http://dx.doi.org/10.1016/j.transproceed.2008.02.051.
25. Lopes CT, Rosin EC, Cordeiro JA, Bueno V. Cell phenotype evaluation at various sites after skin transplantation and FTY720 plus Sirolimus therapy. Transplant Proc. 2010;42(2):573-7, http://dx.doi.org/10.1016/j.transproceed.2010.01.027.
26. Commodaro AG, Peron JP, Lopes CT, Arslanian C, Belfort R Jr., Rizzo LV, Bueno V. Evaluation of experimental autoimmune uveitis in mice treated with FTY720. Invest Ophtalmol Vis Sci. 2010;51(5):2568-74, http://dx.doi.org/10.1167/iovs.09-4769.
27. Chen H, Wang W, Xie H, Xu X, Wu J, Jiang Z, Zhang M, Zhou L, Zheng S. A pathogenic role of IL-17 at the early stage of corneal allograft rejection. Transpl Immunol. 2009;21(3):155-61, http://dx.doi.org/10.1016/j.trim.2009.03.006.
28. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol. 2002;197(3):322-32, http://dx.doi.org/10.1002/path.1117.
29. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24(2):179-89, http://dx.doi.org/10.1016/j.immuni.2006.01.001.
30. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278(3):1910-4, http://dx.doi.org/10.1074/jbc.M207577200.
31. Mehling M, Lindberg R, Raul F, Kuhle J, Hess C, Kappos L, et al. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology. 2010;75(5)403-10, http://dx.doi.org/10.1212/WNL.0b013e3181ebdd64.
32. Wolf AM, Eller K, Zeiser R, Dürr C, Gerlach UV, Sixt M, Markut L, Gastl G, Rosenkranz AR, Wolf D. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. J Immunol. 2009;183(6):3751-60, http://dx.doi.org/10.4049/jimmunol.0901011.
33. Zhou PJ, Wang H, Shi GH, Wang XH, Shen ZJ, Xu D. Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro. Clin Exp Immunol. 2009;157(1):40-7, http://dx.doi.org/10.1111/j.1365-2249.2009.03942.x.
34. Hester J, Mills N, Shankar S, Carvalho-Gaspar M, Friend P, Wood KJ. Th17 cells in Alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy. Transplantation. 2011;91(7): 744-50.
35. Sewgobind VDKD, van der Laan LJW, Kho MML, Kraaijeveld R, Korevaar SS, Mol W, Weimar W, Baam CC. The calcineurin inhibitor tacrolimus allows the induction of functional CD4+CD25+ regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol. 2010;161(2):364-77.
36. Battaglia M, Stabilini A, Draghici E, Gregori S, Mocchetti C, Bonifacio E. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes. 2006;55(1):40-9, http://dx.doi.org/10.2337/diabetes.55.01.06.db05-0613.
37. Yoshimoto T, Yoshimoto T, Yasuda K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol. 2007;179(7):4415-23.
38. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006;7(9):937-45, http://dx.doi.org/10.1038/ni1376.
39. Li J, Lai X, Liao W, He Y, Liu Y, Gong J. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol. 2011;11(8):962-7, http://dx.doi.org/10.1016/j. intimp.2011.02.010.